Argeris N. Karabelas, Director at REGENXBIO Inc. (RGNX), sold 10,100 shares at $13.45 ($136K) on 2024-08-01, disclosed to the SEC on 2024-08-05.
Scheduled sale ($136k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.45 | 9,600 | $129K | 94.6% |
| 2 | $14.59 | 400 | $6K | 4.3% |
| 3 | $15.00 | 100 | $2K | 1.1% |
| Total | $13.51 avg | 10,100 | $136K | 100% |
| Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |
| VRX | BUY | 2016-08-12 | $99K | — | Filing → |